Tide Microfluidics

Solstice Pharmaceuticals (Formerly Tide Microfluidics) empowers ultrasound diagnostics, through our innovative ultrasound contrast agent which increases the image contrast in ultrasound by 20 times. Key to this innovation is the proprietary technologies to control the size and size distribution of the ultrasound contrast agent produced. This next generation of ultrasound contrast agent is superior reflector of ultrasound, with unique capabilities for both improved diagnostic use as well as opening up therapeutic use such as targeted drug delivery and stimulated uptake. To find out more join us at Solstice Pharmaceuticals: https://lnkd.in/eGP_n9M